查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530024

ATP 检测市场规模、份额、趋势分析报告：按类型、应用、最终用途、地区、细分市场预测，2024-2030 年

ATP Assays Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

ATP检测市场规模和趋势

预计 2023 年全球 ATP 检测市场规模将达到 33.1 亿美元，预计 2024 年至 2030 年复合年增长率为 7.9%。这是由对快速、灵敏检测方法的需求、不断扩大的製药和生物技术研究应用、监管核准以及慢性病负担日益增加所推动的。这些驱动因素凸显了 ATP检测法在医疗、研究和工业领域的重要作用，促进了个人化医疗、药物发现、环境监测、食品安全和品质检测以及疾病控制方面的进步。根据世界卫生组织2022年的报告，食品污染影响全球约6亿人，每年导致200多种疾病，其中包括腹泻等严重症状，导致42万人死亡，每年导致3,300万人死亡。

癌症、糖尿病、心血管疾病和感染疾病等慢性病的盛行率不断上升，推动了诊断测试和疾病管理中对 ATP检测法的需求。根据世界卫生组织 (WHO) 2023 年 7 月发布的报告，1.16 亿人患有B型肝炎，1,000 万人患有C型肝炎，导致癌症、肝硬化和病毒感染，并与肝炎相关死亡有关。 ATP 浓度显示细胞功能障碍和疾病进展，使这些测量成为疾病诊断、预后和监测治疗反应的宝贵工具。由于世界各地的医疗保健系统面临着管理慢性病的挑战，检测可以透过早期检测和个人化治疗策略来帮助改善患者的治疗结果。

受污染的食品含有细菌、病毒、寄生虫和化学物质等有害病原体，构成严重的健康风险。 ATP检测法透过快速、灵敏地检测微生物的存在，对于对抗食品污染至关重要。这些测定测量三磷酸Adenosine。三磷酸Adenosine是所有活细胞中微生物活性的通用指标。 ATP 水平是评估食品表面、设备和加工区域清洁度的可靠指标。快速识别污染源的能力使食品製造商、加工商和监管机构能够立即采取纠正措施，并预防食源性疾病。在食品加工中，这些产品需要即时微生物监测，以监控卫生习惯、检验清洗程序、确保符合安全标准，并在整个供应链中保持食品品质和安全。

创新在推动市场前进方面发挥着至关重要的作用。检测灵敏度、精确度和自动化方面的进步提高了 AP 检测方法的效能和可靠性。製造商正在开发整合生物发光、萤光和化学冷光等最尖端科技的新平台，以提供快速、准确的测量。例如，Promega Corporation 的 RealTime-Glo 细胞外 ATP 测定是一种生物发光方法，旨在检测经历压力、活化和凋亡的细胞释放的 ATP。它是评估可能诱导免疫抗原性细胞死亡的治疗的重要生物标记物，这是免疫反应调节的重要方面。这些进步满足了实验室和诊断环境中对高效能筛检和自动化工作流程不断增长的需求。

全球 ATP 检测市场报告细分

本报告预测了2018年至2030年各子子区隔的收益成长并分析了最新趋势。本研究报告按类型、应用、最终用途和地区对全球 ATP 检测市场进行分类。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 ATP 检测市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 助剂市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业分析-波特五力分析
    • PESTEL分析
  • COVID-19 对 ATP 检测市场的影响
  • 区域层面的价格分析
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东/非洲

第四章 ATP 检测市场：按类型估计和趋势分析

  • 细分仪表板
  • ATP 检测市场：类型变异分析，2023 年和 2030 年

第五章 ATP 检测市场：按应用、估计和趋势分析

  • 细分仪表板
  • ATP 检测市场：2023 年和 2030 年应用变化分析

第六章 ATP 检测市场：依最终用途分类的估算与趋势分析

  • 细分仪表板
  • ATP 检测市场：最终用途变化分析，2023 年和 2030 年

第 7 章 ATP 检测市场：区域、估计和趋势分析

  • 2023 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 2023年主要企业市场占有率分析
    • Thermo Fisher Scientific
    • Promega Corporation
    • PerkinElmer Inc.
    • Becton, Dickinson and Company（BD）
    • Lonza Group Ltd.
    • Danaher Corporation
    • Abcam plc
    • Quest Diagnostics Incorporated
    • Biomerieux SA
    • 3M Company
Product Code: GVR-4-68040-390-2

ATP Assays Market Size & Trends

The global ATP assays market size was estimated at USD 3.31 billion in 2023 and is projected to grow at a CAGR of 7.9% from 2024 to 2030. This is attributed to the demand for rapid and sensitive detection methods, expanding pharmaceutical and biotechnology research applications, regulatory approvals, and the rising burden of chronic diseases. These drivers underscore the critical role of ATP assays in healthcare, research, and industrial sectors, facilitating advancements in personalized medicine, drug discovery, environmental monitoring, food safety and quality testing, and disease management. The 2022 WHO report highlights that food contamination affects about 600 million people globally, leading to over 200 diseases annually, including severe conditions such as diarrhea, resulting in 420,000 deaths and 33 million healthy life years lost.

The increasing prevalence of chronic diseases, such as cancer, diabetes, cardiovascular disorders, and infectious diseases, drives the demand for ATP assays in diagnostic testing and disease management. According to the report published by the World Health Organization (WHO) in July 2023, 116 million people live with hepatitis B and 10 million with hepatitis C, leading to cancer, liver cirrhosis, and viral hepatitis-related deaths, and around 3 million new infections occur annually, with most going undetected In the Western Pacific Region. ATP levels indicate cellular dysfunction and disease progression, making these assays valuable tools for disease diagnosis, prognosis, and monitoring of therapeutic responses. As healthcare systems worldwide face the challenge of managing chronic conditions, assays contribute to improving patient outcomes through early detection and personalized treatment strategies.

Contaminated food contains harmful pathogens like bacteria, viruses, parasites, and chemical substances, posing significant health risks. ATP assays are pivotal in combating food contamination by swiftly and sensitively detecting microbial presence. These assays measure adenosine triphosphate, a universal indicator of microbial activity in all living cells. ATP levels serve as reliable markers for assessing cleanliness in food surfaces, equipment, and processing areas. They enable prompt identification of contamination sources, empowering food manufacturers, processors, and regulators to take immediate corrective actions to prevent foodborne illnesses. In food processing, these products monitor hygiene practices, validate cleaning procedures, ensure compliance with safety standards, and enable real-time microbial monitoring to uphold food quality and safety across supply chains.

Technological innovations play a pivotal role in driving the market forward. Advances in assay sensitivity, accuracy, and automation have enhanced the performance and reliability of AP detection methods. Manufacturers are developing novel platforms integrating cutting-edge technologies such as bioluminescence, fluorescence, and chemiluminescence to provide rapid and precise measurements. For instance, The RealTime-Glo Extracellular ATP Assay by Promega Corporation is a bioluminescent method designed to detect ATP released from cells undergoing stress, activation, or apoptosis. It serves as a pivotal biomarker for assessing treatments that may induce immunogenic cell death, a significant aspect of immune response modulation. These advancements cater to the growing demand for high-throughput screening and automated workflows in research laboratories and diagnostic settings.

Global ATP Assays Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global ATP assays market based on type, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030¬)
  • Luminometric ATP Assays
  • Enzymatic ATP Assays
  • Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
  • Cell-based ATP Assays
  • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Drug Discovery and Development
  • Clinical Diagnostics
  • Environmental Testing
  • Food Safety and Quality Testing
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Hospital and Diagnostics Laboratories
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

  • Latin America

Brazi

Argentina

  • Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. ATP Assays Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Analysis - Porter's
      • 3.2.3.1. Bargaining power of the suppliers
      • 3.2.3.2. Bargaining power of the buyers
      • 3.2.3.3. Threats of substitution
      • 3.2.3.4. Threats from new entrants
      • 3.2.3.5. Competitive rivalry
    • 3.2.4. PESTEL Analysis
      • 3.2.4.1. Political landscape
      • 3.2.4.2. Economic and Social landscape
      • 3.2.4.3. Technological landscape
  • 3.3. Impact of COVID 19 on ATP Assays market
  • 3.4. Pricing Analysis, at Regional Level
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. MEA

Chapter 4. ATP Assays Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. ATP Assays Market: Type Movement Analysis, 2023 & 2030 (USD Million)
    • 4.2.1. Luminometric ATP Assays
      • 4.2.1.1. Luminometric ATP Assays Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Enzymatic ATP Assays
      • 4.2.2.1. Enzymatic ATP Assays Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. Cell-based ATP Assays
      • 4.2.3.1. Cell-based ATP Assays Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.4. Others
      • 4.2.4.1. Other Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.5. Graspers/ Clips

Chapter 5. ATP Assays Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. ATP Assays Market: Application Movement Analysis, 2023 & 2030 (USD Million)
    • 5.2.1. Drug Discovery and Development
      • 5.2.1.1. Drug Discovery and Development Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. Clinical Diagnostics
      • 5.2.2.1. Clinical Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.2.3. Environmental Testing
      • 5.2.3.1. Environmental Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.2.4. Food Safety and Quality Testing
      • 5.2.4.1. Food Safety and Quality Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.2.5. Others
      • 5.2.5.1. Other Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. ATP Assays Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. ATP Assays Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
    • 6.2.1. Pharmaceutical and Biotechnology Companies
      • 6.2.1.1. Pharmaceutical and Biotechnology Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. Academic and Research Institutes
      • 6.2.2.1. Academic and Research Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Hospital and Diagnostics Laboratories
      • 6.2.3.1. Hospital and Diagnostics Laboratories Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. ATP Assays Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2023
    • 8.3.2. Thermo Fisher Scientific
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Type benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Promega Corporation
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Type benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. PerkinElmer Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Type benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Becton, Dickinson and Company (BD)
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Type benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Lonza Group Ltd.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Type benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Danaher Corporation
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Type benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Abcam plc
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Type benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Quest Diagnostics Incorporated
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Type benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Biomerieux SA
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Type benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. 3M Company
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Type benchmarking
      • 8.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global ATP Assays Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 Global ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8 North America ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 Canada ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Canada ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18 Mexico ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 Mexico ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Mexico ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 21 Europe ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Europe ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Europe ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 UK ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 UK ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 UK ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 Germany ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 Germany ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 Germany ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 31 France ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 France ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 France ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 34 Italy ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Italy ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Italy ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 Spain ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Spain ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Spain ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40 Denmark ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 Denmark ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Denmark ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43 Sweden ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Sweden ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Sweden ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 Norway ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Norway ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Norway ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 53 Japan ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 Japan ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 Japan ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56 China ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 57 China ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 China ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59 India ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 India ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 India ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 62 South Korea ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 South Korea ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 South Korea ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 Australia ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 66 Australia ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 Australia ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 68 Thailand ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 69 Thailand ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 70 Thailand ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 71 Latin America ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 72 Latin America ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 Latin America ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Latin America ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 75 Brazil ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 Brazil ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Brazil ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78 Argentina ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 79 Argentina ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Argentina ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 81 Middle East and Africa ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East and Africa ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 83 Middle East and Africa ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 South Africa ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 86 South Africa ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 South Africa ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91 UAE ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 92 UAE ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 UAE ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait ATP Assays Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 ATP Assays market segment scope and defination
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 ATP Assays market: Type movement analysis
  • Fig. 17 ATP Assays market: Type segment dashboard
  • Fig. 18 ATP Assays market Type outlook: Key takeaways
  • Fig. 19 Luminometric ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Enzymatic ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Bioluminescence Resonance Energy Transfer (BRET) ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Cell-based ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Others ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 ATP Assays market: Application movement analysis
  • Fig. 25 ATP Assays market Application outlook: Key takeaways
  • Fig. 26 Drug Discovery and Development ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Clinical Diagnostics ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Environmental Testing ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Food Safety and Quality TestingATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Other ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 ATP Assays market: End Use movement analysis
  • Fig. 32 ATP Assays market End Use outlook: Key takeaways
  • Fig. 33 Pharmaceutical and Biotechnology Companies ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Academic and Research Institutes ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Hospital and Diagnostics Laboratories ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Regional outlook, 2023 & 2030
  • Fig. 37 Regional market dashboard
  • Fig. 38 Regional market place: Key takeaways
  • Fig. 39 North America ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 44 UK ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 47 France ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy implantable Market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 54 China ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 55 India ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 62 MEA ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 67 Heat map analysis
  • Fig. 68 Market differentiators